The gut microbiome is made up of hundreds of different species of bacteria. These influence a person’s physical and mental health. When these bacteria are studied in the laboratory in pure culture, they often behave completely differently to how they do in their natural environment. It is therefore particularly important for microbiome research to determine what functions the individual microbes perform within the microbial community and how they can be specifically influenced.
A team of researchers from the University of Vienna and Boston University has now succeeded in combining two microscopy techniques (stimulated Raman scattering microscopy and two-photon microscopy) to analyse samples at high speed. This direct functional analysis makes it possible to visualise bacteria and the feeding behaviour of individual bacterial cells. To achieve this, the microbiome sample is fed a stable (non-radioactive) isotope. Microbes that consume this isotope are thereby simultaneously labelled with it. “In line with the principle ‘you are what you eat’, the feeding behaviour of individual bacterial cells can thus be analysed via their isotope content,” the researchers write in a press release. In addition, different bacterial species are labelled with fluorescent colours.
“Due to the considerable time required, the analyses available to date were only suitable for the dominant members of the microbiome at any given time. Many others were overlooked,” explains Michael Wagner, a microbiologist and deputy head of the Centre for Microbiology and Environmental Systems Science. “Using the new high-speed method, we have now been able to determine, in a very short time, the isotopic composition of more than 30,000 bacterial cells from human gut samples following incubation with various sugars found in the gut mucus,” reports Wagner.
It emerged that certain Clostridia (a type of gut bacterium) play an important and previously unknown role in the breakdown of the mucosal sugar fucose. “This finding is remarkable, as fucose represents the interface between the mucosa and the gut microbiome. However, one in five people are unable to carry out fucosylation of the intestinal mucus and are at increased risk of inflammatory bowel disease. Current research projects are, amongst other things, attempting to use targeted probiotics to reduce the risk of disease in these individuals. For this to succeed, it is important to understand which microbes benefit from fucose breakdown in the gut and which may be lacking in affected individuals,” explains Fátima Pereira, co-first author of the study and senior postdoc in the Vienna research group.
The new method is also being used to investigate how medicines commonly prescribed for the treatment of Parkinson’s disease and schizophrenia affect the human gut microbiome.
Reference:
University of Vienna
Ge X, Pereira FC, Mitteregger M et al., SRS-FISH: A high-throughput platform linking microbiome metabolism to identity at the single-cell level, Proceedings of the National Academy of Sciences (PNAS), 119: e2203519119.
DOI: https://doi.org/10.1073/pnas.2203519119
#gutmicrobiome #clostridia #fucose #Parkinson’s #schizophrenia #medicine #science